Heritage, Apotex plan to pay $49.1 million to settle drug pricing scheme allegations

Heritage, Apotex plan to pay $49.1 million to settle drug pricing scheme allegations
Two pharmaceutical companies will pay $49.1 million to resolve allegations that they inflated prices, reduced competition and restricted access to generic drugs, Attorney General Josh Kaul said Thursday. 
To access this content, you must purchase a Premium membership, or log in if you are a member.

STAY INFORMED ON THE STATE’S MOST PRESSING HEALTHCARE ISSUES AND INITIATIVES.

Subscribe here for a FREE 14 day trial of our daily news roundup.

You have Successfully Subscribed!

Pin It on Pinterest